Robert G. Savage, Director at EPICEPT CORP (EPCT), bought 25,000 shares at $1.44 ($35K) on 2007-12-13, disclosed to the SEC on 2007-12-14.
Open-market purchase of $35k EPCT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.35 | 5,000 | $7K | 19.5% |
| 2 | $1.35 | 7,000 | $9K | 27.3% |
| 3 | $1.36 | 3,000 | $4K | 11.8% |
| 4 | $1.42 | 5,000 | $7K | 20.5% |
| 5 | $1.44 | 5,000 | $7K | 20.8% |
| Total | $1.38 avg | 25,000 |
| $35K |
| 100% |
| Filing → |
| EPCT | BUY | 2007-08-20 | $6K | — | Filing → |